Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
L-malic acid is a naturally occurring dicarboxylic acid that serves as a critical intermediate in the citric acid cycle (Krebs cycle), playing a vital role in cellular energy production by facilitating the transport of NADH from the cytosol to the mitochondria. Pharmaceutically, it is utilized in various capacities: as a sialagogue in topical formulations (such as sprays or lozenges) to treat xerostomia (dry mouth) by stimulating saliva production through its acidic profile; as an electrolyte replenisher in parenteral nutrition; and in combination therapies for liver protection and recovery. Beijing Minkan Baicao Pharmaceutical Technology includes L-malic acid in its development pipeline, likely focusing on standardized formulations or generic versions for the Chinese market.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on l-malic acid.